Results 21 to 30 of about 5,782,070 (237)

Creative Gardens: Towards Digital Commons [PDF]

open access: yes, 2016
date-added: 2015-03-04 03:12:21 +0000 date-modified: 2015-04-01 06:49:53 +0000date-added: 2015-03-04 03:12:21 +0000 date-modified: 2015-04-01 06:49:53 +0000This work was supported by the Arts and Humanities Research Council, CreativeWorks London Hub ...
Lockwood, J, Briscoe, G
core   +4 more sources

Uvod u analitičku kemiju

open access: yesCroatica Chemica Acta, 2016
Njegomir Radić, Lea Kukoč Modun: Uvod u analitičku kemiju [Introduction to Analytical Chemistry] Školska knjiga, d. d., Zagreb, 2016 780 pages ◦ ISBN 978-953-0-30931-9 This work is licensed under a Creative Commons Attribution 4.0 International ...
Vlasta Allegretti Živčić
doaj   +1 more source

Assessing the Potential Toward Open Educational Practices in Kyrgyzstan

open access: yesOpen Praxis, 2018
The study was undertaken to understand the propensity for increased engagement with open educational practices (OEP), to include methods prioritizing student-centered teaching & learning, and awareness, use, and development of open educational ...
Anita R Walz, Jyldyz Bekbalaeva
doaj   +3 more sources

Fact Sheet on Creative Commons & Open Science

open access: yes, 2017
This information guide contains questions and responses to common concerns surrounding open science and the implications of licensing data under Creative Commons licences.
Creative Commons UK
core   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Structural insights into an engineered feruloyl esterase with improved MHET degrading properties

open access: yesFEBS Letters, EarlyView.
A feruloyl esterase was engineered to mimic key features of MHETase, enhancing the degradation of PET oligomers. Structural and computational analysis reveal how a point mutation stabilizes the active site and reshapes the binding cleft, expading substrate scope.
Panagiota Karampa   +5 more
wiley   +1 more source

Creative Commons licenses - what's the right license for me?

open access: yes, 2022
The library of the Federal Institute for Drugs and Medical Devices (BfArM) in Bonn assists BfArM employees not only in obtaining the desired literature for scientific work, but also in publishing.
Sollmann, A, Boos, B
core   +1 more source

Valosin‐containing protein counteracts ATP‐driven dissolution of FUS condensates through its ATPase activity in vitro

open access: yesFEBS Letters, EarlyView.
Biomolecular condensates formed by fused in sarcoma (FUS) are dissolved by high ATP concentrations yet persist in cells. Using a reconstituted system, we demonstrate that valosin‐containing protein (VCP), an AAA+ ATPase, counteracts ATP‐driven dissolution of FUS condensates through its D2 ATPase activity.
Hitomi Kimura   +2 more
wiley   +1 more source

2nd Anglo-Croatian Medicinal Symposium on Macrocycles Medicinal Chemistry and Beyond-the-Rule-of-Five

open access: yesCroatica Chemica Acta, 2016
Second international symposium was jointly organized by the Biological and Medicinal Sector of the Royal Society of Chemistry (RSC) and by the Croatian Chemical Society (CCS) on October 17–18, 2016, in Zagreb, Croatia.
Vitomir Šunjić
doaj   +1 more source

Hyperosmotic stress induces PARP1‐mediated HPF1‐dependent mono(ADP‐ribosyl)ation

open access: yesFEBS Letters, EarlyView.
Sorbitol‐induced hyperosmotic stress rapidly induces reversible mono(ADP‐ribosyl)ation (MARylation) on PARP1 without the signs of genotoxic signaling. We show that PARP1 autoMARylation is HPF1 dependent and forms hydroxylamine‐resistant O‐glycosidic linkages.
Anna Georgina Kopasz   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy